Rigvir® Cancer Treatment In Germany Or At Home: How to Qualify, Treatment Period and Cost
If radiotherapy or chemotherapy no longer helps (or if you’re not willing to handle weight loss and fatigue), virotherapy with Rigvir® in its core might be the answer. Whether you’ve learnt about Rigvir® treatment from Truth About Cancer series or your local oncologist, take a minute to find out about:
- how to qualify for Rigvir® therapy?
- how long Rigvir® therapy lasts?
- how much Rigvir® therapy costs?
Riga virus was registered in Latvia in 2004, and in a year the medicine entered the pharmaceutical market. Since then, Rigvir® has reached 20 more countries including Germany.
Reasons for Rigvir® Treatment in Germany: the Chief Oncologist Is On the Team That Evaluates Your Case
There are some more reasons to visit Germany for virotherapy.
First of all, the local specialists have profound experience in treating cancer patients from Europe and North America. Moreover, you’ll feel like home as both medical and administrative staff speaks English fluently.
Secondly, local oncologists blend latest clinical research with home-like attitude while sharing their knowledge with you about how Rigvir® works, what should be taken into account when administering the drug, and how to manage follow-up programs.
Thirdly, when you apply for virotherapy treatment in Germany, such experienced oncologists look into your medical documentation to assess your case and give personalized recommendations. The final decision is always taken by the Chief Oncologist who participates in the assessment process.
Fourthly, flexibility is on your side: depending on your health situation the oncologists may offer you procedures additionally to Rigvir® including:
- Buserelin Therapy
- Naturopathic Complex Program
- Targeted Radiotherapy
- Neural Therapy
All treatment options require that you first submit your medical files for the free case evaluation. Fill in the form on the right so we get back to you immediately with more details.
As for the mode of action, Rigvir® enters a human body through intramuscular injections. Being specifically designed to target cancer cells, Rigvir®:
- reaches and destroys them from the inside;
- doesn’t affect healthy cells located around the tumor;
- causes no side effects except for slightly higher than usual body temperature (37.5° C);
- is often used to prevent or get rid of metastases.
You Can Qualify For Rigvir® Treatment Once You Collect The Required Medical Reports
The 20th century has been marked with an invention made by Aina Muceniece, a Latvian scientist, who unveiled a virus ECHO-7 able to destroy cancer cells. The drug is now called Rigvir®, abbreviated from Riga virus, and is a nonpathogenic virus. It means that the virus injections will not cause any diseases.
To help oncologists evaluate your case, please collect as many of your medical files as possible including:
- biopsy (or pathology report)
- lab tests
- cytology report
- PET/CT/MRI scan results
Whether you are searching for Rigvir for breast cancer or kidney cancer, the applying process is always the same. Once you provide the files, it takes 1-2 business days for the team of oncologists in Germany to evaluate it. The assessment is necessary because it shows if virotherapy can improve your health condition.
If you get approved for the Rigvir therapy, here’s what you need to know. The clinic in Germany offering virotherapy is located close to Munich. Therefore, you will have to purchase your flight ticket to the international airport in Munich. The patient coordinator will pick you up right after you arrive and bring you to the clinic by car. The length of treatment varies depending on your health situation and includes meals, accommodation, and transfers. The average cost of such treatment package is roughly €5,000-6,000 per week.
Any questions? Click the button below and we’ll get in touch with you within 24 hours but usually immediately.
What Scientific Research and Patients Tell About Rigvir® Treatment
A course of virotherapy can be either a single tool to overcome the diseases or an addition to chemotherapy or radiotherapy. The survival rate in melanoma patients, who used Rigvir®, has raised in 4-6 times compared to those who didn’t, states the study published in Melanoma Research in October 2015: